Skip to main content
TipRanks
Go Ultimate75% OFF

Quest Pharmatech (QPT) Financial Statements

6 Followers

Quest Pharmatech Financial Overview

Quest Pharmatech's market cap is currently $3.38M. The company's EPS TTM is ―; its P/E ratio is 0.68; Quest Pharmatech has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Jan 24Jan 23Jan 22Jan 21Jan 20
Income Statement
Total Revenue―――――
Gross Profit―――――
Operating Income$ -1.83M$ -3.93M$ -790.57K$ -1.07M$ -13.63M
EBITDA$ -2.99M$ -64.85M$ -84.99M$ 190.11M$ -13.20M
Net Income$ -3.02M$ -64.89M$ -85.04M$ 190.06M$ -6.18M
Balance Sheet
Cash & Short-Term Investments―――――
Total Assets$ 24.48M$ 26.80M$ 91.03M$ 175.61M$ 4.45M
Total Debt$ 1.00M$ 1.00M$ 14.00K$ 304.37K$ 2.74M
Net Debt$ 283.04K$ 625.34K$ -250.34K$ 105.25K$ 285.83K
Total Liabilities$ 1.32M$ 1.11M$ 622.60K$ 389.44K$ 20.95M
Stockholders' Equity―――――
Cash Flow
Free Cash Flow$ -342.42K―$ -170.78K$ -2.52M$ -6.38M
Operating Cash Flow―――――
Investing Cash Flow―――――
Financing Cash Flow―――――

Currency in USD